More News

20 Jun 2018 TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody
19 Jun 2018 Kallyope and Novo Nordisk announce collaboration to discover novel therapeutics for obesity and diabetes
19 Jun 2018 NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma's new subsidiary Fortify Therapeutics
14 Jun 2018 Arsanis Out-Licenses Preclinical Stage Klebsiella pneumoniae Monoclonal Antibodies from ASN300 Program
11 Jun 2018 BridgeBio Pharma Enters into Agreement to Acquire Late Stage Therapy for Ultra-Rare Disorder from Alexion; Launches Origin Biosciences to Develop and Commercialize Therapy
11 Jun 2018 Nkarta Therapeutics Announces Exclusive License to Natural Killer Cell Technology From National University of Singapore and St. Jude Children’s Research Hospital
11 Jun 2018 Alexion and Complement Pharma Announce Partnership to Co-Develop Pre-Clinical Complement Inhibitor for Neurodegenerative Disorders
11 Jun 2018 Translate Bio Announces Agreement with Sanofi Pasteur to Develop Vaccines for Infectious Diseases using Novel mRNA Technology
08 Jun 2018 Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania
08 Jun 2018 Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke
06 Jun 2018 Microbiotica Enters into Microbiome Collaboration with Genentech
06 Jun 2018 Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases
05 Jun 2018 Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B
04 Jun 2018 Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing Innovative Oncology Therapeutics
04 Jun 2018 Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China
02 Jun 2018 MolMed and Glycostem announce the execution of a binding term sheet for the development and manufacturing of allogeneic CAR-NK therapies
02 Jun 2018 Nerviano Medical Sciences announces Collaboration and License Agreement with Merck to discover small molecule inhibitors of certain anticancer targets
01 Jun 2018 Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Leukemia, Myelodysplastic Syndromes, Multiple Myeloma, Small-Cell Lung And Other Small-Cell Cancers
01 Jun 2018 Bayer and MD Anderson Cancer Center Collaborate to Strengthen Oncology Translational Research and Clinical Development
31 May 2018 F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma
31 May 2018 Celltrion and Yonsei University Health System Team up to Develop New Drugs for Cerebrovascular Diseases
31 May 2018 ASKA and Takeda Enter into Licensing Agreement for Relugolix in Women's Health Indications
30 May 2018 Report Package: TCR-Based Antibody and T-Cell Immunotherapy
29 May 2018 CERENIS Therapeutics and University of North Texas Health Science Center Announce a Strategic Initiative to Develop New HDL-Based Pharmaceutical Products
25 May 2018 Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up